Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines, has appointed Linda Jónsdóttir as Chief Financial Officer (CFO).

Joel Morales, who has served as CFO of Alvotech since 2020, based in the U.S., has decided to step down. He will continue supporting Alvotech in an advisory capacity to ensure a smooth transition.

About Linda Jónsdóttir

Jónsdóttir is a highly experienced international executive with a strong background in finance and corporate leadership. She has held senior roles across a range of industries, including banking, food technology, transportation, and healthcare. She will be based in Iceland.

Jónsdóttir held senior roles for 15 years at Marel, a global leader in food processing technology, including Director of Treasury and Investor Relations, Chief Financial Officer and Chief Operating Officer, until stepping down in 2024. She has also served on various boards, including in banking, private equity funds, and at the Icelandic Chamber of Commerce.

“It’s a great pleasure to join Alvotech, which is a unique company domestically as well as an emerging leader in its field internationally. It’s been thrilling to watch Alvotech’s rapid growth, and its prospects are equally exciting. I look forward to working with an exceptional team, building on this strong foundation and history of achievement,” said Jónsdóttir.

More Alvotech News

Alvotech recently expanded its capacity for assembly and packaging with the acquisition of Ivers-Lee Group, a business specializing in providing assembly and packaging services for the pharmaceutical sector.